Significant Reduction in Operating Expenses
Total operating expenses for Q3 2025 were $11.5 million, a 35% decrease compared to $17.8 million in Q3 2024.
Successful Fundraising
In October, the company strengthened its balance sheet with approximately $5.9 million in gross proceeds from a registered direct offering.
Improvement in Surgical Procedure Efficiency
The time to complete an IPOM ventral hernia dropped from an average of 40 minutes to 14 minutes, indicating a dramatic increase in system stability and reliability.